Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
34541
Description
A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481
Lien
https://clinicaltrials.gov/show/NCT02470481
Mots-clés
Versions (3)
- 19/01/2019 19/01/2019 -
- 11/02/2020 11/02/2020 - Christian Arras
- 04/03/2020 04/03/2020 - Christian Arras
Détendeur de droits
see on clinicaltrials.gov
Téléchargé le
19 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Psoriatic Arthritis NCT02470481
Eligibility Psoriatic Arthritis NCT02470481
- StudyEvent: Eligibility
Similar models
Eligibility Psoriatic Arthritis NCT02470481
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ID.1
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
ID.2
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
ID.3
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
ID.4
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
ID.5
Item
an established diagnosis of psoriatic arthritis
boolean
ID.6
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
ID.7
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
ID.8
Item
a history of employment in or are currently employed in the healthcare industry; or
boolean
ID.9
Item
participated in the translation and linguistic validation of the earp questionnaire
boolean